pharmaceuticals | Science and Enterprise

Results of a pilot test show a smartphone app makes a common test for the pregnancy complication preeclampsia simpl… https://t.co/AN5bKtBQrG
about 6 hours ago
New post on Science and Enterprise: App Automates, Simplifies Test for Preeclampsia https://t.co/lSyEXavP4X #Science #Business
about 6 hours ago
Computer scientists in the U.K. and France created techniques for adding a refined sense of touch to highly sensiti… https://t.co/ilWVpMNqZb
about 13 hours ago
New post on Science and Enterprise: Touch Senses Added to Synthetic Skin, Robot Arm https://t.co/KMpa31SgZP #Science #Business
about 13 hours ago
The NBI is in decline since reaching its peak for the year in the spring, erasing all of the gains for the year at… https://t.co/PF5ud7Vlk3
about 2 days ago

Implanted Overdose Rescue Device Being Developed

By Alan, on October 16th, 2019%

An implanted device that senses an overdose of opioid drugs and dispenses an emergency rescue medicine is in development by two university labs. . . . → Read More: Implanted Overdose Rescue Device Being Developed

Early Results Show Anti-Depressive Drug Effects

By Alan, on October 15th, 2019%

Initial results from a clinical trial show a drug designed to supplement first-line treatments helps reduce symptoms of major depressive disorder. . . . → Read More: Early Results Show Anti-Depressive Drug Effects

Real-World Evidence Assessed for Cancer Drug Trials

By Alan, on October 15th, 2019%

Two medical technology companies are evaluating real-world evidence from patients to simulate randomized clinical trials for testing new cancer treatments. . . . → Read More: Real-World Evidence Assessed for Cancer Drug Trials

Trial to Test CBD for Parkinson’s-Related Psychosis

By Alan, on October 14th, 2019%

A clinical trial is planned to test cannabidiol, or CBD, derived from cannabis as a treatment for hallucinations and delusions among people with Parkinson’s disease. . . . → Read More: Trial to Test CBD for Parkinson’s-Related Psychosis

Nanoparticles Designed to Cross Blood-Brain Barrier

By Alan, on October 11th, 2019%

Nanoscale particles derived from viruses are shown in tests with lab mice to cross the blood-brain barrier, and reach nerve cells in the brain. . . . → Read More: Nanoparticles Designed to Cross Blood-Brain Barrier

Companies Developing Hemophilia Gene Editing Therapy

By Alan, on October 10th, 2019%

A partnership between drug maker Novo Nordisk and biotechnology company bluebird bio is designing a treatment for hemophilia with gene-editing proteins. . . . → Read More: Companies Developing Hemophilia Gene Editing Therapy

Merck Gaining Gut Microbe Technology for Vaccines

By Alan, on October 8th, 2019%

Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines. . . . → Read More: Merck Gaining Gut Microbe Technology for Vaccines

Dementia Drug Candidate in Preclinical Tests

By Alan, on October 7th, 2019%

A study is underway of a new treatment approach for dementia that targets inflammation and microscopic bleeding in the brain that can accompany Alzheimer’s disease. . . . → Read More: Dementia Drug Candidate in Preclinical Tests

Nanotech Crispr Delivery in Development

By Alan, on October 2nd, 2019%

Researchers in biochemistry and structural biology are designing a technique using nanoscale particles to safely deliver edited genes as a cancer treatment. . . . → Read More: Nanotech Crispr Delivery in Development

Novartis, Microsoft Partner on A.I.

By Alan, on October 2nd, 2019%

Drug maker Novartis is collaborating with Microsoft to extend the company’s adoption of artificial intelligence into many of its corporate functions. . . . → Read More: Novartis, Microsoft Partner on A.I.

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise